Annual Total Debt
$2.54 M
-$1.49 M-36.97%
31 December 2023
Summary:
Celldex Therapeutics annual total debt is currently $2.54 million, with the most recent change of -$1.49 million (-36.97%) on 31 December 2023. During the last 3 years, it has fallen by -$939.00 thousand (-26.98%). CLDX annual total debt is now -83.21% below its all-time high of $15.14 million, reached on 31 December 2011.CLDX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$3.09 M
+$702.00 K+29.43%
01 September 2024
Summary:
Celldex Therapeutics quarterly total debt is currently $3.09 million, with the most recent change of +$702.00 thousand (+29.43%) on 01 September 2024. Over the past year, it has increased by +$241.00 thousand (+8.47%). CLDX quarterly total debt is now -99.23% below its all-time high of $401.00 million, reached on 30 September 1997.CLDX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.0% | +8.5% |
| 3 y3 years | -27.0% | +0.3% |
| 5 y5 years | +100.0% | -17.4% |
CLDX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.0% | at low | -23.5% | +46.0% |
| 5 y | 5 years | -37.0% | -23.5% | +46.0% | |
| alltime | all time | -83.2% | -99.2% |
Celldex Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.09 M(+29.4%) |
| June 2024 | - | $2.38 M(+12.8%) |
| Mar 2024 | - | $2.11 M(-16.8%) |
| Dec 2023 | $2.54 M(-37.0%) | $2.54 M(-10.7%) |
| Sept 2023 | - | $2.85 M(-12.6%) |
| June 2023 | - | $3.25 M(-10.8%) |
| Mar 2023 | - | $3.65 M(-9.5%) |
| Dec 2022 | $4.03 M(+32.6%) | $4.03 M(+11.2%) |
| Sept 2022 | - | $3.63 M(-9.5%) |
| June 2022 | - | $4.01 M(+51.8%) |
| Mar 2022 | - | $2.64 M(-13.1%) |
| Dec 2021 | $3.04 M(-12.6%) | $3.04 M(-1.2%) |
| Sept 2021 | - | $3.08 M(+10.9%) |
| June 2021 | - | $2.78 M(-11.4%) |
| Mar 2021 | - | $3.14 M(-9.9%) |
| Dec 2020 | $3.48 M(-4.8%) | $3.48 M(-8.6%) |
| Sept 2020 | - | $3.81 M(+25.3%) |
| June 2020 | - | $3.04 M(-19.7%) |
| Mar 2020 | - | $3.79 M(+3.6%) |
| Dec 2019 | $3.66 M(>+9900.0%) | $3.66 M(-2.1%) |
| Sept 2019 | - | $3.73 M(-15.2%) |
| June 2019 | - | $4.41 M(-15.8%) |
| Mar 2019 | - | $5.23 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $10.06 M(-11.3%) |
| Dec 2012 | $11.34 M(-25.1%) | $11.34 M(-12.9%) |
| Sept 2012 | - | $13.02 M(-8.6%) |
| June 2012 | - | $14.24 M(-8.4%) |
| Mar 2012 | - | $15.54 M(+2.6%) |
| Dec 2011 | $15.14 M(+40.0%) | $15.14 M(+0.3%) |
| Sept 2011 | - | $15.11 M(-3.3%) |
| June 2011 | - | $15.62 M(+3.9%) |
| Mar 2011 | - | $15.03 M(+38.9%) |
| Dec 2010 | $10.82 M(>+9900.0%) | $10.82 M(-18.7%) |
| Sept 2010 | - | $13.31 M(+0.6%) |
| June 2010 | - | $13.22 M(-7.2%) |
| Mar 2010 | - | $14.25 M(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $229.00 K(+3.6%) |
| June 2009 | - | $221.00 K(-40.3%) |
| Mar 2009 | - | $370.00 K(+69.7%) |
| Dec 2008 | $218.00 K(>+9900.0%) | $218.00 K(-77.1%) |
| Sept 2008 | - | $952.70 K(-5.8%) |
| June 2008 | - | $1.01 M(-5.4%) |
| Mar 2008 | - | $1.07 M(>+9900.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2007 | - | $0.00(-100.0%) |
| June 2007 | - | $575.70 K(-88.6%) |
| Mar 2007 | - | $5.06 M(+9.1%) |
| Dec 2006 | $4.64 M(+122.4%) | $4.64 M(>+9900.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(-100.0%) |
| Mar 2006 | - | $2.21 M(+6.1%) |
| Dec 2005 | $2.09 M(+1019.4%) | $2.09 M(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2004 | $186.50 K(>+9900.0%) | $186.50 K(>+9900.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2001 | - | $49.80 K(-60.1%) |
| June 2001 | - | $124.80 K(-37.5%) |
| Mar 2001 | - | $199.60 K(-27.3%) |
| Dec 2000 | $274.50 K(-51.2%) | $274.50 K(-19.1%) |
| Sept 2000 | - | $339.20 K(-17.8%) |
| June 2000 | - | $412.60 K(-15.7%) |
| Mar 2000 | - | $489.50 K(-13.0%) |
| Dec 1999 | $562.90 K(-64.8%) | $562.90 K(-59.8%) |
| Sept 1999 | - | $1.40 M(+16.7%) |
| June 1999 | - | $1.20 M(-20.0%) |
| Mar 1999 | - | $1.50 M(-6.3%) |
| Dec 1998 | $1.60 M(0.0%) | $1.60 M(0.0%) |
| Sept 1998 | - | $1.60 M(0.0%) |
| June 1998 | - | $1.60 M(0.0%) |
| Mar 1998 | - | $1.60 M(0.0%) |
| Dec 1997 | $1.60 M(>+9900.0%) | $1.60 M(-99.6%) |
| Sept 1997 | - | $401.00 M(+11.9%) |
| June 1997 | - | $358.50 M(-5.1%) |
| Mar 1997 | - | $377.70 M(>+9900.0%) |
| Dec 1996 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 1996 | - | $200.00 K(0.0%) |
| June 1996 | - | $200.00 K(0.0%) |
| Mar 1996 | - | $200.00 K(0.0%) |
| Dec 1995 | $200.00 K(-60.0%) | $200.00 K(0.0%) |
| Sept 1995 | - | $200.00 K(0.0%) |
| June 1995 | - | $200.00 K(-60.0%) |
| Mar 1995 | - | $500.00 K(0.0%) |
| Dec 1994 | $500.00 K(0.0%) | $500.00 K(0.0%) |
| Sept 1994 | - | $500.00 K(0.0%) |
| June 1994 | - | $500.00 K(0.0%) |
| Mar 1994 | - | $500.00 K(0.0%) |
| Dec 1993 | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(0.0%) |
| Dec 1992 | $0.00(0.0%) | - |
| Oct 1992 | - | $0.00(0.0%) |
| July 1992 | - | $0.00(0.0%) |
| Apr 1992 | - | $0.00(0.0%) |
| Apr 1992 | $0.00(0.0%) | - |
| Jan 1992 | - | $0.00(0.0%) |
| Oct 1991 | - | $0.00(0.0%) |
| July 1991 | - | $0.00(0.0%) |
| Apr 1991 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1991 | - | $0.00(0.0%) |
| Oct 1990 | - | $0.00(0.0%) |
| July 1990 | - | $0.00(0.0%) |
| Apr 1990 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1990 | - | $0.00(0.0%) |
| Oct 1989 | - | $0.00(0.0%) |
| July 1989 | - | $0.00(0.0%) |
| Apr 1989 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1989 | - | $0.00(0.0%) |
| Oct 1988 | - | $0.00(0.0%) |
| July 1988 | - | $0.00(0.0%) |
| Apr 1988 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1988 | - | $0.00(0.0%) |
| Oct 1987 | - | $0.00(0.0%) |
| July 1987 | - | $0.00(0.0%) |
| Apr 1987 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1987 | - | $0.00(0.0%) |
| Oct 1986 | - | $0.00(0.0%) |
| July 1986 | - | $0.00(0.0%) |
| Apr 1986 | $0.00 | $0.00(0.0%) |
| Jan 1986 | - | $0.00(0.0%) |
| Oct 1985 | - | $0.00(0.0%) |
| July 1985 | - | $0.00 |
FAQ
- What is Celldex Therapeutics annual total debt?
- What is the all time high annual total debt for Celldex Therapeutics?
- What is Celldex Therapeutics annual total debt year-on-year change?
- What is Celldex Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly total debt year-on-year change?
What is Celldex Therapeutics annual total debt?
The current annual total debt of CLDX is $2.54 M
What is the all time high annual total debt for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total debt is $15.14 M
What is Celldex Therapeutics annual total debt year-on-year change?
Over the past year, CLDX annual total debt has changed by -$1.49 M (-36.97%)
What is Celldex Therapeutics quarterly total debt?
The current quarterly total debt of CLDX is $3.09 M
What is the all time high quarterly total debt for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total debt is $401.00 M
What is Celldex Therapeutics quarterly total debt year-on-year change?
Over the past year, CLDX quarterly total debt has changed by +$241.00 K (+8.47%)